PathologyWatch has announced $2M in extension funding from Neue Fund, Bioventures GmbH, Lateral Capital, BeniVC, and Sky Ventures. The company has raised over $10M total capital to date.

PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through two programs, ValueWatch and BusinessWatch, dermatology clinics and hospitals can improve operational efficiency by speeding up workflow and improve patient outcomes by utilizing the PathologyWatch expert professional team and partner laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology.